Wegovy in India

Semaglutide 2.4mg — the highest dose, specifically approved for chronic weight management

15–17%

Average weight loss

2.4mg

Maximum weekly dose

₹5,660/mo

Starting dose cost

₹14,000/mo

Maintenance dose cost

Book Consultation WhatsApp Us

What makes Wegovy different from Ozempic?

Both are semaglutide — but Wegovy is dosed at 2.4mg weekly vs Ozempic's maximum of 2mg. The higher dose produces greater appetite suppression and more weight loss.

✓15–17% body weight loss (vs 10–15% with Ozempic)

✓Specifically approved for obesity — not just diabetes

✓SELECT trial: 20% reduction in cardiovascular events

✓Approved in India June 2025 — first in India for obesity

✓Price cut 48% in April 2026 vs initial launch price

Who is Wegovy for?

✓BMI ≥30 (obese)

✓BMI ≥27 with at least one weight-related condition (diabetes, hypertension, heart disease)

✓Patients who want maximum weight loss from a GLP-1 drug

✓Patients at high cardiovascular risk who also need weight management

⚠️Note: Prescription from endocrinologist required. MoH April 2026 guidelines apply.

Dose Escalation Schedule & Cost in India (After April 2026 Cut)

Wegovy must be escalated slowly over 16 weeks to minimise GI side effects. Do not rush the escalation.

Dose	Schedule	₹/Week	₹/Month
0.25mg	Weeks 1–4	₹1,415	₹5,660
0.5mg	Weeks 5–8	₹1,800	₹7,200
1.0mg	Weeks 9–12	₹2,200	₹8,800
1.7mg	Weeks 13–16	₹3,000	₹12,000
2.4mg ★	Week 17+ (maintenance)	₹3,500	₹14,000

★ Maintenance dose. Total escalation period: 16 weeks minimum before reaching 2.4mg maintenance.

The weight regain concern: STEP trial data shows patients regain ~60% of lost weight within 1 year of stopping Wegovy. This means Wegovy is likely a lifelong treatment for most patients. Factor this into your cost planning.

Ready to start Wegovy in India?

Our endocrinology team provides a full assessment, prescription, and ongoing monitoring plan.

Book Consultation Wegovy vs Bariatric Surgery →